Cancer Rehabilitation, A New Discipline Based upon Multidisciplinary Collaboration

Authors

  • Shan Su Cancer Rehabilitation Medicine (Clinical) Research Center, Shanghai International Medical Center

DOI:

https://doi.org/10.30564/jams.v5i2.5231

Abstract

Cancer Rehabilitation is a new discipline, a combination of tumor medication, immunology, psychology, nutritional science and exercise physiology etc.. The core of cancer rehabilitation is the therapy of natural immunology, which aims at activating T-cells, and restoring the bone marrow function impaired during chemo-radiation therapy. Cancer rehabilitation seeks to achieve the gradual recovery of the immune system, which in turn hinders recurrence and metastasis. In addition, with the help of psychological consultation, nutritional and physical exercise guidance, cancer patients may have a better chance at managing the risk of recurrence and metastasis, extending life expectancy with an improved quality of life. 

Keywords:

Cancer rehabilitation, Therapy of natural immunology, Immune activation Immune reconstruction, Immune response management, Cancer rehabilitation psychology, Cancer rehabilitation nutritional science, Cancer rehabilitation exercise physiology

References

[1] Chen, L., 2011. Research progress on the effect of chemotherapy on tumor immune function. Journal of Clinical Oncology. 16(9).

[2] 2022.V1 version of NCCN Oncology Clinical Practice Guidelines: Small Cell Lung Cancer.

[3] Verma, R., Foster, R.E., Horgan, K., et al., 2016. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer. Breast Cancer Research. 18, 10.

[4] DOI: https://doi.org/10.1186/s13058-015-0669-x

[5] Zhang, Sh.L., 2014. Nursing of Oral Ulcers Induced by Radiotherapy in Patients with Nasopharyngeal Carcinoma. World Latest Medical Information Digest. 14(1).

[6] He, H., Zhu, J., Peng, N., et al., 2011. Investigation of gastrointestinal symptoms in cancer chemotherapy patients. Nursing Research. (025)004.

[7] Tak, W., Mak Mary, E., 2010. Saunders Introduction to Immune Response.

[8] Zheng, R., Zhang, S., Zeng, H. et al., 2022. Cancer Incidence and Mortality in China, 2016. Journal of the National Cancer Center. 2(1).

[9] Ren, K.L., 2019. Research progress of CAR-T immunotherapy. Article No.: 2096-43902019-0044-02.

[10] Acoulay, E., Castro, P., Maamar, A., et al., 2021. Outcomes in Patients Treated with Chimeric Antigen Receptor T-cell Therapy who were Admitted to Intensive Care (CARTTAS): An International, Multicentre, Observational Cohort Study. The Lancet Haematology. 8(5).

[11] Postow, M., Chesney, J., Pavlick, A., et al., 2015. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma. New England Journal of Medicine. 372, 2006-2017.

[12] DOI: https://doi.org/10.1056/NEJMoa1414428

[13] Wu, Y., Wang, S., 1995. Study on the Immune Function of Cordyceps Sinensis on Patients with Pulmonary Heart Disease (Bailing Capsule). Chinese Journal of Experimental Prescriptions. 1(1), 45.

[14] Wang, Y.L., Zhou, H.P., 2000. The Influence of Taijiquan on Heart Rate. China Sports Science and Technology. 36(2).

Downloads

Issue

Vol. 5 , Iss. 2 (July 2022)

Article Type

Articles

License

Copyright and Licensing

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

Journal of Advances in Medicine Science publishes accepted manuscripts under Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Authors who submit their papers for publication by Journal of Advances in Medicine Science agree to have the CC BY-NC 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for non-commercial use. As long as you follow the license terms and original source is properly cited, anyone may copy, redistribute the material in any medium or format, remix, transform, and build upon the material.

License Policy for Reuse of Third-Party Materials

If a manuscript submitted to the journal contains the materials which are held in copyright by a third-party, authors are responsible for obtaining permissions from the copyright holder to reuse or republish any previously published figures, illustrations, charts, tables, photographs, and text excerpts, etc. When submitting a manuscript, official written proof of permission must be provided and clearly stated in the cover letter.
The editorial office of the journal has the right to reject/retract articles that reuse third-party materials without permission.

Journal Policies on Data Sharing

We encourage authors to share articles published in our journal to other data platforms, but only if it is noted that it has been published in this journal.